What does Generate Biomedicines, Inc. do?
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development. Its product includes GB-0895, is an investigational…
What is Generate Biomedicines, Inc.'s P/E and P/B ratio?
Generate Biomedicines, Inc. has a P/E ratio of -5.2 and a P/B ratio of 3.60.
What is Generate Biomedicines, Inc.'s debt-to-equity ratio?
Generate Biomedicines, Inc. has a debt-to-equity ratio of 0.14.
How much does Generate Biomedicines, Inc. owe compared with what it owns?
Generate Biomedicines, Inc. owes $0.19 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Generate Biomedicines, Inc.'s Positivity rank?
Generate Biomedicines, Inc. is ranked #4,214 of 6,775 companies globally and #2,037 of 4,000 in United States on PositoAI, with a Positivity Score of 19,799.
Does Generate Biomedicines, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Generate Biomedicines, Inc..
Where can I read the latest news about Generate Biomedicines, Inc.?
Recent headlines about Generate Biomedicines, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Generate Biomedicines, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Generate Biomedicines, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.